Collaboration Partners
We are honoured to partner with leading experts and organisations in respiratory health to advance our understanding of difficult to treat asthma. Our partners bring a wealth of knowledge and expertise to the ISAR initiative, helping us to improve patient outcomes and shape the future of best clinical practice in severe asthma.
OPC Global: A research organisation with 10 years of experience. OPC Global Has successfully collaborated with renowned research institutes globally contributing towards the delivery of over 48 research projects and publications. It is an contributor of OPCRD academic research and collaborations.
-
Co-sponsorship, Project Management and Delivery
-
Co-funding the initial setup of ISAR (50%)
-
Data standardisation, eCRF, processing, hosting and guardianship
.png){kind=logo}
OPRI: Real world database research organization working to improve the understanding of risk-factors for poorly-controlled disease, the effectiveness of drugs, devices and patient management strategies in real life. OPRI ultimately aims to inform healthcare professionals on how to integrate and optimize these factors to drive better disease management.
The OPC and OPRI team:
Karen Hosking
Data Analytics Manager
AstraZeneca: A global biopharmaceutical business delivering medicines to patients through innovative science and excellence in development and commercialisation.
-
Co-sponsorship
-
Co-founding the initial set up of ISAR
The AstraZeneca team:
Neil Martin
Omnichannel Engineering Lead
Andrew Menzies-Gow
Global Medical Head Respiratory Biologics
Trung Tran
Senior Director, Epidemiology
REG: A not-for-profit investigator-led academic initiative comprising of over 420 respiratory/allergy experts globally collaborating on independent, academic real-life and comparative effectiveness research in respiratory medicine.
-
Academic partner
-
Forum for discussion (REG Summit, Severe Asthma & Biomarkers Working Group)
-
Anonymized Data & Ethics Protocol Transparency (ADEPT) committee